Skip to main content
. 2021 Jan 3;44(3):307–313. doi: 10.1016/j.htct.2020.10.964

Table 2.

Cytopenias and CD4 count at baseline and after ≥6 months of ARV treatment (n = 302).

Baseline ≥6 months of ARV treatment
Frequency (%) Frequency (%)
Any Cytopenia 166 (54.97) 78 (25.83)
Anemia 138 (45.70) 45 (14.90)
 Hb 11−11.9 g/dL (F) or
 12.9 g/dL (M)
92 (30.46) 32 (10.60)
 Hb 8–10.9 g/dL 43 (14.24) 13 (4.30)
 Hb <8 g/dL 3 (0.99) 0
Leukopenia 67 (22.19) 41 (13.58)
 WBC 3.0–4.49 × 109/L 53 (17.55) 40 (13.25)
 WBC 2.0–2.99 × 109/L 10 (3.31) 1 (0.33)
 WBC <2.0 × 109/L 4 (1.32) 0
Thrombocytopenia 15 (4.97) 3 (0.99)
 Plt 71–149 × 109/L 12 (3.97) 3 (0.99)
 Plt 20–70 × 109/L 1 (0.33) 0
 Plt <20 × 109/L 2 (0.66) 0
CD4 count
 <200 cells/µL 199 (65.89) 104 (34.44)
 ≥200 cells/µL 103 (34.11) 198 (65.56)

Hb: hemoglobin; M: male; F: female; WBC: white blood cell count; Plt: platelet count.